Search Results for: name
ALG11 Gene Congenital disorder of glycosylation type Ip Genetic Test Cost
The ALG11 gene plays a critical role in the process of glycosylation, which is the attachment of sugars to proteins and lipids, a critical process necessary for proper cellular function. Mutations in the ALG11 gene can lead to a rare condition known as Congenital Disorder of Glycosylation Type Ip (CDG-Ip), a genetic disorder that affects multiple systems of the body, including the nervous system, liver, and coagulation processes, leading to a wide range of potential symptoms such as developmental delay, liver dysfunction, and coagulation abnormalities. To diagnose this condition, a specific genetic test targeting the ALG11 gene can be conducted. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic testing service. The test is designed to identify mutations in the ALG11 gene that are responsible for CDG-Ip, providing essential information for accurate diagnosis and management of the disorder. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the comprehensive information it provides to healthcare providers, patients, and their families. Conducting this test at DNA Labs UAE involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory using advanced genetic sequencing technologies to detect mutations in the ALG11 gene. The results of this test can confirm a diagnosis of CDG-Ip, guide treatment decisions, and provide important information for genetic counseling of affected families.
SRD5A3 Gene Congenital disorder of glycosylation type Iq Genetic Test Cost
The SRD5A3 gene congenital disorder of glycosylation type Iq genetic test is a specialized diagnostic tool available at DNA Labs UAE. This genetic test is designed to identify mutations in the SRD5A3 gene, which are associated with Congenital Disorder of Glycosylation Type Iq (CDG-Iq), a rare genetic condition. CDG-Iq affects the normal process of glycosylation, which is critical for the proper function of various proteins and lipids in the body. Symptoms of CDG-Iq can vary widely among individuals but may include developmental delay, intellectual disability, vision problems, and abnormalities in liver function. The test is performed using a blood sample from the patient, which is then analyzed using advanced genetic sequencing techniques to detect any mutations in the SRD5A3 gene. This precise genetic testing allows for an accurate diagnosis of CDG-Iq, enabling healthcare providers to tailor treatment and management plans to the specific needs of the patient. The cost of the SRD5A3 gene congenital disorder of glycosylation type Iq genetic test at DNA Labs UAE is 4400 AED. Given the specialized nature of this test and the detailed information it provides, it represents a crucial step towards understanding and managing this rare genetic disorder. Early diagnosis through this genetic test can significantly impact the quality of life for individuals with CDG-Iq by facilitating early interventions and support.
STT3A Gene Congenital disorder of glycosylation type Iw Genetic Test Cost
The STT3A gene plays a critical role in the process of glycosylation, which is the attachment of sugars to proteins, a vital process for proper protein function. Mutations in the STT3A gene can lead to a rare condition known as Congenital Disorder of Glycosylation Type Iw (CDG-Iw). This genetic disorder can affect multiple systems in the body, leading to a wide range of symptoms that may include developmental delay, neurological issues, and abnormalities in liver function. To diagnose CDG-Iw, a specific genetic test is available at DNA Labs UAE. This test involves analyzing the patient's DNA to identify mutations in the STT3A gene that are indicative of the disorder. The cost of this genetic test is 4400 AED. By confirming the presence of STT3A gene mutations, this test enables healthcare providers to make an accurate diagnosis, which is crucial for managing the condition effectively. Early diagnosis and intervention can significantly improve the quality of life for individuals with CDG-Iw.
CPOX Gene Coproporphyria Genetic Test Cost
The CPOX Gene Coproporphyria Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the CPOX gene. These mutations are responsible for a condition known as Hereditary Coproporphyria (HCP), a rare type of porphyria that affects the body's ability to produce heme, an essential component of hemoglobin. HCP is characterized by a range of symptoms including abdominal pain, neuropathy, and, in severe cases, neurological complications. The test, priced at 4400 AED, involves analyzing the patient's DNA to detect specific genetic alterations in the CPOX gene, enabling precise diagnosis and facilitating appropriate management and treatment strategies for affected individuals. By identifying the genetic basis of the condition, this test plays a crucial role in the clinical approach to managing Hereditary Coproporphyria, offering hope for better outcomes through personalized medicine.
LPA Gene Coronary artery disease susceptibility to Genetic Test Cost
The "LPA Gene Coronary Artery Disease Susceptibility Genetic Test" is a cutting-edge diagnostic tool available at DNA Labs UAE, designed to assess an individual's genetic predisposition to developing coronary artery disease (CAD). This test specifically examines variations in the LPA gene, which have been linked to an increased risk of CAD. The LPA gene encodes for a protein called lipoprotein(a), high levels of which in the blood can lead to the development of plaques in the arteries, thereby increasing the risk of heart attacks and other cardiovascular diseases. By analyzing a person's DNA, the test identifies specific mutations or polymorphisms within the LPA gene that are associated with elevated lipoprotein(a) levels and, consequently, a higher risk of coronary artery disease. This information can be invaluable for individuals with a family history of CAD or those who have other risk factors for the disease. The test is conducted at DNA Labs UAE, a facility known for its state-of-the-art genetic testing services. The cost of the LPA Gene Coronary Artery Disease Susceptibility Genetic Test is 4400 AED. The results from this test can provide individuals with critical insights into their genetic risk for CAD, allowing them to take proactive measures in consultation with healthcare professionals to mitigate this risk through lifestyle changes, medication, or other interventions deemed necessary based on the test findings and overall health assessment.
VKORC1 Gene Coumarin resistance Genetic Test Cost
The VKORC1 Gene Coumarin Resistance Genetic Test is a specialized diagnostic tool used to identify variations in the VKORC1 gene that can affect an individual's response to coumarin-based anticoagulants, such as warfarin. These medications are commonly prescribed to prevent blood clots, but their effectiveness and safety are highly dependent on precise dosing, which can vary significantly among individuals due to genetic differences. The VKORC1 gene plays a crucial role in the vitamin K cycle, which is essential for blood clotting, and mutations in this gene can lead to either increased sensitivity or resistance to coumarin drugs, necessitating adjustments to standard dosing to avoid complications such as bleeding or thrombosis. The test is conducted at DNA Labs UAE, a leading facility in genetic testing and personalized medicine. The cost of the test is 4400 AED, which reflects the comprehensive analysis and professional interpretation that accompany the genetic screening. By opting for this test, patients and healthcare providers can make more informed decisions regarding the use of coumarin-based anticoagulants, leading to safer and more effective treatment outcomes for conditions that require blood-thinning medication.
CYP2C9 Gene CoumarinWarfarin resistance due to CYP2C9 variants Genetic Test Cost
The CYP2C9 gene plays a crucial role in drug metabolism, particularly in the processing of Coumarin and Warfarin, commonly used anticoagulants. Variants in the CYP2C9 gene can significantly affect an individual's response to these medications, leading to resistance or increased sensitivity, which can impact treatment efficacy and safety. The genetic test for CYP2C9 variants is a valuable tool in personalized medicine, allowing healthcare providers to tailor anticoagulant dosages more accurately to the patient's genetic makeup. At DNA Labs UAE, the test for identifying CYP2C9 variants related to Coumarin/Warfarin resistance is available. This test is crucial for patients who are starting or currently on Coumarin or Warfarin therapy, as it helps in determining the most effective dosage and minimizing the risk of adverse drug reactions. The cost of the test is 4400 AED, which is an investment in ensuring safer and more effective treatment outcomes for patients requiring anticoagulant therapy. By understanding a patient's genetic predisposition to Coumarin/Warfarin resistance, healthcare providers can make informed decisions, potentially reducing the risk of bleeding or thrombotic events associated with improper dosing.
CR1 Gene CR1 deficiency Genetic Test Cost
The CR1 gene, also known as Complement Receptor 1, plays a crucial role in the immune system by helping to regulate the complement system, which is a part of the immune system that enhances the ability of antibodies and phagocytic cells to clear pathogens from an organism. A deficiency in the CR1 gene can lead to various immune system disorders and may increase susceptibility to infections and certain autoimmune diseases. To diagnose CR1 deficiency and understand its implications for an individual's health, a genetic test can be conducted. This test examines the CR1 gene for mutations that could lead to a deficiency in its function. It is a critical tool for individuals experiencing symptoms that may be linked to CR1 deficiency or for those with a family history of related immune system disorders. In the United Arab Emirates, DNA Labs UAE offers this specialized genetic test. The cost of the CR1 gene deficiency genetic test is 4400 AED. Conducted in a state-of-the-art laboratory by experienced geneticists and healthcare professionals, this test provides valuable insights into an individual's genetic makeup, specifically concerning the CR1 gene. The results can help guide treatment plans, preventive measures, and provide a better understanding of potential health risks related to CR1 deficiency.